FeesSafety
Pluang+

Outset Medical to report Q3 2026 financial results on Nov 4 with CEO and CFO call.

Company Fundamentals
21 Oct 2026, 23:05 WIB
GlobeNewsWire
View Source
Neutral
Outset Medical to report Q3 2026 financial results on Nov 4 with CEO and CFO call.

Outset Medical, a medical technology company specializing in dialysis solutions, will announce its third quarter 2026 financial results after market close on November 4, 2026. CEO Leslie Trigg and CFO Renee Gaeta will hold a conference call the same day to discuss the results. The company is known for its Tablo Hemodialysis System, which simplifies dialysis treatment and is used by over 1,000 U.S. healthcare facilities. Investors can access the call live or archived via the company's website.

Outset Medical's upcoming Q3 2026 financial results provide context for healthcare sector activity on Pluang. For readers following healthcare stocks, here is Pluang's market snapshot as of Oct 22, 2026 03:02 WIB: Among 150 priced health-sector US stocks, 73 rose and 75 fell. Notable movers include Charles River Laboratories Intl. Inc (CRL) at USD 344.63 with a 1-day change of +9.25% and 100% buy order activity, Liquidia Corporation (LQDA) at USD 38.98 with +7.24% but 91% sell order activity, and DexCom, Inc. (DXCM) at USD 79.99 with a -6.71% change and 100% sell order activity. Typical hold times vary from 2 to 62 days across these stocks.

More News

Security National Financial Q3 earnings drop 38.6% amid tough mortgage market and rising rates

Security National Financial Q3 earnings drop 38.6% amid tough mortgage market and rising rates

Security National Financial Corporation reported a 38.6% drop in after-tax earnings for Q3 2026, falling to $6.17 million due to challenging mortgage market conditions and increased interest rates. The mortgage segment faced a $2.65 million loss driv...

Company Fundamentals
Bearish
1 hour ago
JIADE Ltd prices $1.2M direct offering to fund education services expansion

JIADE Ltd prices $1.2M direct offering to fund education services expansion

JIADE Ltd announced a registered direct offering of 6.67 million Class A shares at $0.18 each, raising approximately $1.2 million before fees. The funds will support its comprehensive education services for adult institutions in China, including soft...

Company Fundamentals
Neutral
1 hour ago
Bureau Veritas reports 453.9M shares and 567.9M exercisable voting rights as of October 31, 2026

Bureau Veritas reports 453.9M shares and 567.9M exercisable voting rights as of October 31, 2026

Bureau Veritas disclosed its share and voting rights count as of October 31, 2026, reporting 453,899,720 shares outstanding. The company has a theoretical total of 579,429,535 voting rights, with 567,882,134 exercisable voting rights. This update ref...

Company Fundamentals
Neutral
1 hour ago
Quadient reports total shares and voting rights as of October 30, 2026.

Quadient reports total shares and voting rights as of October 30, 2026.

Quadient S.A. has disclosed its monthly update on the total number of ordinary shares and voting rights as of October 30, 2026. The company reports 34,468,912 total shares and theoretical voting rights, with 34,091,172 net voting rights. This disclos...

Company Fundamentals
Neutral
3 hours ago
Quadient reports 34.47M shares and 34.09M net voting rights as of October 30, 2026

Quadient reports 34.47M shares and 34.09M net voting rights as of October 30, 2026

Quadient S.A. disclosed its monthly update on shares and voting rights as of October 30, 2026. The company has a total of 34,468,912 ordinary shares and a net total of 34,091,172 voting rights. This information is relevant for shareholders and invest...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App